EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ten tips for successful assessment of risk of bias in randomized trials using the RoB 2 tool: Early lessons from Cochrane

Theresa H M Moore iD, Julian P T Higgins, Kerry Dwan

Cochrane Evidence Synthesis and Methods · 2023-12 · 1 (10)

DOI: 10.1002/cesm.12031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cochrane Evidence Synthesis and Methods, online erschienen am 03.12.2023. Verfasst von Theresa H M Moore und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cochrane Editorial and Methods Department London UK. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

RoB 2 is a tool used by systematic reviewers to assess risk of bias in randomized trials. Over a period of 19 months working as editors for Cochrane, we saw many instances where users of RoB 2 frequently applied the tool in ways the developers had not intended, despite availability of detailed guidance, webinars and FAQs.

Methods

In this paper we highlight the ten main issues that we observed, with the aims of optimising the application of the RoB 2 tool, avoiding some of the frequent misapplications of the tool.

Results

Issues noted included failure to state an effect of interest, applying the tool to an entire study rather than to a specific numerical result, omitting key signaling questions and relying on outdated views of causes of bias.

Conclusion

Such omissions and misapplications can lead to overly harsh or lenient assessments of bias with potential to change the confidence we have in an evidence base of randomized trials. We recommend that teams planning to use RoB 2 include at least one member familiar with the RoB 2 detailed guidance and that they use the free resources, such as webinars and FAQs, from the developers of RoB 2 and Cochrane. Our ten tips should be useful to non‐Cochrane systematic reviewers as well as to peer reviewers and editors in Cochrane and other journals.

Schlagwörter

Stichwörter der Autor:innen

BiasCochraneMethodologyQuality assessmentQuality improvementRandomized controlled trialsRandomized trialsRisk of biasRoB 2Systematic reviews

Autor:innen und Institutionen

  • Cochrane Editorial and Methods Department London UK.
  • NIHR Applied Research Collaboration West (ARC West) University Hospitals Bristol and Weston NHS Foundation Trust Bristol UK.
  • Population Health Sciences, Bristol Medical School University of Bristol Bristol UK.
  • Liverpool School of Tropical Medicine Liverpool UK.

ORCID-Profile: Theresa H M Moore

Zitieren

APA

Moore, T. H. M., Higgins, J. P. T., & Dwan, K. (2023). Ten tips for successful assessment of risk of bias in randomized trials using the RoB 2 tool: Early lessons from Cochrane. Cochrane Evidence Synthesis and Methods, 1(10). https://doi.org/10.1002/cesm.12031

Vancouver

Moore THM, Higgins JPT, Dwan K. Ten tips for successful assessment of risk of bias in randomized trials using the RoB 2 tool: Early lessons from Cochrane. Cochrane Evidence Synthesis and Methods. 2023;1(10). doi:10.1002/cesm.12031

BibTeX
@article{Moore2023,
  author = {Moore, Theresa H M and Higgins, Julian P T and Dwan, Kerry},
  title = {Ten tips for successful assessment of risk of bias in randomized trials using the RoB 2 tool: Early lessons from Cochrane},
  journal = {Cochrane Evidence Synthesis and Methods},
  year = {2023},
  volume = {1},
  number = {10},
  doi = {10.1002/cesm.12031}
}
Kostenlos starten →